Associations of three major physiological stress systems with suicidal ideation and suicide attempts in patients with a depressive and/or anxiety disorder |
Wiebenga |
2022 |
Fat metabolism is associated with telomere length in six population-based studies |
van der Spek |
2022 |
Higher thyrotropin leads to unfavorable lipid profile and somewhat higher cardiovascular disease risk: evidence from multi-cohort Mendelian randomization and metabolomic profiling |
Van Vliet |
2021 |
Basal and LPS-stimulated inflammatory markers and the course of anxiety symptom |
Van Eeden |
2021 |
Hair cortisol, obesity and the immune system: Results from a 3 year longitudinal study |
Van der Valk |
2021 |
Plasma androgens and the presence and course of depression in a large cohort of women |
De Wit |
2021 |
Incident Major Depressive Disorder Predicted by Three Measures of Insulin Resistance: A Dutch Cohort Study |
Watson |
2021 |
Association of Insulin Resistance With Depression Severity and Remission StatusDefining a Metabolic Endophenotype of Depression |
Watson |
2021 |
An integrated approach to understand biological stress system dysregulation across depressive and anxiety disorders |
Vinkers, C |
2021 |
How childhood trauma and recent adverse events are related to hair cortisol levels in a large adult cohort |
Oresta |
2021 |
The association between plasma tryptophan catabolites and depression: The role of symptom profiles and inflammation |
Milaneschi |
2021 |
Cortical thickness and resting-state cardiac function across the lifespan: A cross-sectional pooled mega-analysis |
Koenig |
2021 |
An integrative study of five biological clocks in somatic and mental health |
Jansen, R |
2021 |
The association between genetically determined ABO blood types and major depressive disorder |
Garvert, L |
2021 |
Plasma androgens and the presence and course of depression in a large cohort of men |
de Wit |
2021 |
Metabolomic profiles discriminating anxiety from depression |
de Kluiver |
2021 |
Investigating the relationships between unfavourable habitual sleep and metabolomic traits: evidence from multi-cohort multivariable regression and Mendelian randomization analyses |
Bos |
2021 |
Metabolomics dissection of depression heterogeneity and related cardiometabolic risk |
Alsheri |
2021 |
Metabolic Age Based on the BBMRI-NL 1 H-NMR Metabolomics Repository as Biomarker of Age-related Disease |
van den Akker EB |
2020 |
Novel neuronal surface autoantibodies in plasma of patients with depression and anxiety |
Shenghua Zong |
2020 |
Genetic correlations and genome-wide associations of cortical structure in general population samples of 22,824 adults |
Hofer |
2020 |
Investigating data-driven biological subtypes of sychiatric disorders using specification-curve analysis |
Beijers |
2020 |
Childhood trauma and dysregulation of multiple biological stress systems in adulthood: Results from the Netherlands Study of Depression and Anxiety (NESDA) |
Kuzminskaite |
2020 |
Predicting the course of anxiety disorders: The role of biological parameters |
Bosman |
2020 |
Metabolic Age Based on the BBMRI-NL 1 H-NMR Metabolomics Repository as Biomarker of Age-related Disease |
van den Akker |
2020 |
Association of food groups with depression and anxiety disorders |
Gibson-Smith D |
2020 |
Bidirectional longitudinal associations of omega-3 polyunsaturated fatty acid plasma levels with depressive disorders. |
Thesing CS |
2020 |
Using network analysis to examine links between individual depressive symptoms, inflammatory markers, and covariates. |
Fried EI |
2019 |
Metabolomics profile in depression: a pooled analysis of 230 metabolic markers in 5283 cases with depression and 10,145 controls. |
Bot M |
2020 |
Letter: Response to “International Society for Nutritional Psychiatry Research Practice Guidelines for Omega-3 Fatty Acids in the Treatment of Major Depressive Disorder” by Guu et al. (2019). |
Thesing CS |
2019 |
Fatty acids and recurrence of major depressive disorder: combined analysis of two Dutch clinical cohorts. |
Thesing CS |
2019 |
Depressive symptom clusters in relation to body weight status: results from two large European multicenter studies. |
Baldofski S |
2019 |
Increased serum levels of leptin and insulin in both schizophrenia and major depressive disorder: A cross-disorder proteomics analysis. |
Çakici N |
2019 |
The association of depression and anxiety with cardiac autonomic activity: The role of confounding effects of antidepressants. |
Hu MX |
2019 |
The impact of depression and anxiety treatment on biological aging and metabolic stress: study protocol of the MOod treatment with antidepressants or running (MOTAR) study. |
Lever-van Milligen BA |
2019 |
Delayed sleep-onset and biological age: late sleep-onset is associated with shorter telomere length. |
Wynchank DS |
2019 |
Sleep, circadian rhythm, and physical activity patterns in depressive and anxiety disorders: A 2-week ambulatory assessment study (actigraphy/EMA). |
Difrancesco S |
2019 |
Association of a priori dietary patterns with depressive symptoms: a harmonised meta-analysis of observational studies. |
Nicolaou M |
2019 |
Smoking does not accelerate leucocyte telomere attrition: a meta-analysis of 18 longitudinal cohorts. |
Bateson M |
2019 |
Involvement of inflammatory gene expression pathways in depressed patients with hyperphagia |
de Kluiver H |
2019 |
Major depression and enhanced molecular senescence abnormalities in young and middle-aged adults. |
Diniz BS |
2019 |
Evaluating the evidence for biotypes of depression: Methodological replication and extension of Drysdale et al (2017). |
Dinga R |
2019 |
Longitudinal association between depression and inflammatory markers: results from the Netherlands Study of Depression and Anxiety. |
Lamers F |
2019 |
Large-scale plasma metabolome analysis reveals alterations in HDL metabolism in migraine |
Onderwater GLJ |
2019 |
Association of food groups with depression and anxiety disorders |
Ginson-Smith D |
2019 |
Unraveling the association between depression and telomere length using genomics |
Verhoeven JE |
2019 |
Body mass index in obsessive-compulsive disorder |
Abramovitch A |
2019 |
Depression and eating styles are independently associated with dietary intake |
Paans NPG |
2019 |
Methylome-wide association findings for major depressive disorder overlap in blood and brain and replicate in independent brain samples |
Aberg KA |
2018 |
Circulating insulin-like growth factor I modulates mood and is a biomarker of vulnerability to stress: from mouse to man |
Santi A |
2018 |
Genetic analysis of over 1 million people identifies 535 new loci associated with blood pressure traits |
Evangelou E |
2018 |
Association between depression, anxiety, and antidepressant use With T-wave amplitude and QT-interval. |
HU MX |
2018 |
Biomarker-based subtyping of depression and anxiety disorders using Latent Class Analysis. A NESDA study |
Beijers L |
2019 |
Bidirectional prospective associations between cardiac autonomic activity and inflammatory markers. |
Hu MX |
2018 |
The reciprocal relationship between physical activity and depression: Does age matter? |
Wassink-Vossen S |
2018 |
The association of omega-3 fatty acid levels with personality and cognitive reactivity |
Thesing CS |
2018 |
Leukocyte telomere length and personality: associations with the Big Five and Type D personality traits |
Schoormans D |
2018 |
Metabolic and inflammatory markers: associations with individual depressive symptoms |
Lamers F |
2018 |
The association between metabolic syndrome, obesity-related outcomes, and ADHD in adults with comorbid affective disorders. |
Wynchank D |
2018 |
Testosterone in human studies: Modest associations between plasma and salivary measurements. |
de Wit |
2018 |
Eating styles in major depressive disorder: Results from a large-scale study |
Paans NPG |
2018 |
The role of anxious distress in immune dysregulation in patients with major depressive disorder. |
Gaspersz R |
2017 |
Leptin dysregulation is specifically associated with major depression with atypical features: evidence for a mechanism connecting obesity and depression. |
Milaneschi |
2017 |
Does obesity along with major depression or anxiety lead to higher use of health care and costs? A 6-year follow-up study. |
Nigatu YT |
2017 |
Omega-3 and omega-6 fatty acid levels in depressive and anxiety disorders. |
Thesing CS |
2018 |
Uric acid in major depressive and anxiety disorders |
Black CN |
2018 |
Temporal stability and drivers of change in cardiac autonomic nervous system activity. |
Hu MX |
2017 |
Corticosteroid use in obese and non-obese individuals: a multi-cohort study. |
Savas M |
2017 |
The association between the hypothalamic pituitary adrenal axis and tryptophan metabolism in persons with recurrent major depressive disorder and healthy controls |
Sorgdrager FJH |
2017 |
[Associations between depression, anxiety and telomere length in a large Dutch psychiatric cohort study]. |
Verhoeven JE |
2017 |
Which biopsychosocial variables contribute to more weight gain in depressed persons? |
Paans |
2017 |
Attention-deficit/hyperactivity disorder symptoms and stress-related biomarkers. |
Vogel SW |
2017 |
The association between three major physiological stress systems and oxidative DNA and lipid damage |
Black CN |
2017 |
Biological stress systems, adverse life events, and the improvement of chronic multisite musculoskeletal pain across a 6-year follow-up. . |
Generaal E |
2017 |
Influences of lifestyle factors on cardiac autonomic nervous system activity over time. |
Hu MX |
2017 |
Identification of an immune-neuroendocrine biomarker panel for detection of depression: a joint effects statistical approach. |
Chan MK |
2016 |
Oxidative stress in major depressive and anxiety disorders, and the association with antidepressant use; results from a large adult cohort. |
Black CN |
2017 |
Blood-based immune-endocrine biomarkers of treatment response in depression |
Chan MK |
2016 |
Six-year trajectory of objective physical function in persons with depressive and anxiety disorders |
Lever-van Milligen B |
2017 |
The association between personality traits, cognitive reactivity and body mass index is dependent on depressive and/or anxiety status |
Paans NP |
2016 |
Depression and cardiovascular disease: Epidemiological evidence on their linking mechanisms |
Penninx BW |
2017 |
ADHD, circadian rhythms and seasonality |
Wynchank DS |
2016 |
The association between metabolic syndrome, obesity-related outcomes, and ADHD in adults with comorbid affective disorders. |
Wynchank D |
2016 |
Basal autonomic activity, stress reactivity, and increases in metabolic syndrome components over time |
Hu MX |
2016 |
Depressive and anxiety disorders and short leukocyte telomere length: mediating effects of metabolic stress and lifestyle factors |
Révész D |
2016 |
Serum proteomic profiles of depressive subtypes |
Lamers F |
2016 |
Variation in serum biomarkers with sex and female hormonal status: implications for clinical tests |
Ramsey JM |
2016 |
Cytokine production capacity in depression and anxiety |
Vogelzangs N |
2016 |
Sex differences in serum markers of Major Depressive Disorder in the Netherlands Study of Depression and Anxiety (NESDA) |
Ramsey JM |
2016 |
Depressive and anxiety disorders showing robust, but non-dynamic, 6-year longitudinal association with short leukocyte telomere length |
Verhoeven JE |
2016 |
Bidirectional prospective associations of metabolic syndrome components with depression, anxiety, and antidepressant use |
Hiles SA |
2016 |
Attention-deficit hyperactivity disorder symptoms add risk to circadian rhythm sleep problems in depression and anxiety |
Bron TI |
2016 |
The role of obesity measures in the development and persistence of major depressive disorder |
Gibson-Smith D |
2016 |
The brain-derived neurotrophic factor pathway, life stress, and chronic multi-site musculoskeletal pain |
Generaal E |
2016 |
Plasma insulin-like growth factor I levels are higher in depressive and anxiety disorders, but lower in antidepressant medication users. |
Bot M |
2016 |
Differential autonomic nervous system reactivity in depression and anxiety during stress depending on type of stressor |
Hu MX |
2016 |
Baseline biopsychosocial determinants of telomere length and 6-year attrition rate |
Révész D |
2016 |
Serum biomarkers predictive of depressive episodes in panic disorder |
Gottschalk MG |
2016 |
Major depressive disorder, antidepressant use, and subsequent 2-year weight change patterns in the Netherlands Study of Depression and Anxiety |
Gibson-Smith D |
2016 |
Sociodemographic and lifestyle determinants of plasma oxidative stress markers 8-OHdG and F2-Isoprostanes and associations with metabolic syndrome |
Black CN |
2016 |
Chronotype associations with depression and anxiety disorder in a large cohort study |
Antypa N |
2016 |
Towards a blood-based diagnostic panel for bipolar disorder. |
Haenisch F |
2016 |
The association of early and recent psychosocial life stress with leukocyte telomere length. |
Verhoeven JE |
2015 |
A social hormone: Salivary testosterone and extraversion in a large cohort study. |
Smeets-Janssen MMJ |
2015 |
Determinants of hair cortisol and hair cortisone concentrations in adults. |
Staufenbiel SM |
2015 |
Where you live may make you old: the association between perceived poor neighborhood quality and leukocyte telomere length. |
Park M |
2015 |
Discovery of serum biomarkers predicting development of a subsequent depressive episode in social anxiety disorder. |
Gottschalk MG |
2015 |
Serum proteomic profiling of major depressive disorder. |
Bot M |
2015 |
Disturbances in Hypothalamic-Pituitary-Adrenal axis and immunological activity differentiating between unipolar and bipolar depressive episodes. |
Becking K |
2015 |
Determinants of plasma 25-hydroxyvitamin D levels in healthy adults in the Netherlands. |
van Grootheest G |
2014 |
The role of adiposity in cardiometabolic traits: a mendelian randomization analysis. |
Fall T |
2013 |
Antidepressant use and salivary cortisol in depressive and anxiety disorders. |
Manthey L |
2011 |
Association of vitamin D status with arterial blood pressure and hypertension risk: a mendelian randomisation study. |
Vimaleswaran KS |
2014 |
Major depressive disorder and accelerated cellular aging: results from a large psychiatric cohort study |
Verhoeven J |
2014 |
Telomere length as a marker of cellular ageing is associated with prevalence and progression of metabolic syndrome |
Révész D |
2014 |
Association between serum brain-derived neurotrophic factor and plasma interleukin-6 in major depressive disorder with melancholic features |
Patas K |
2014 |
The metabolic syndrome and related characteristics in major depression: inpatients and outpatients compared: Metabolic differences across treatment settings. |
Luppino F |
2014 |
Increased cortisol awakening response was associated with time to recurrence of major depressive disorder. |
Hardeveld F |
2014 |
Basal inflammation and innate immune response in chronic multisite musculoskeletal pain |
Generaal E |
2014 |
Reduced hypothalamic-pituitary-adrenal axis activity in chronic multi-site musculoskeletal pain: partly masked by depressive and anxiety disorders. |
Generaal E |
2014 |
Low serum BDNF levels in depressed patients cannot be attributed to individual depressive symptoms. |
Bus B |
2014 |
Anxiety disorders and accelerated cellular ageing. |
Verhoeven JE |
2015 |
Metabolic syndrome in patients with bipolar disorder: comparison with major depressive disorder and non-psychiatric controls |
Silarova B |
2015 |
Depression, anxiety and 6-year risk of cardiovascular disease. |
Seldenrijk A |
2015 |
Sleep duration, insomnia, and markers of systemic inflammation: Results from the Netherlands Study of Depression and Anxiety (NESDA). |
Prather AA |
2015 |
The longitudinal joint effect of obesity and major depression on work performance impairment: Findings from the NESDA study. |
Nigatu YT |
2015 |
Association between smoking, nicotine dependence, and BDNF Val Met Polymorphism with BDNF concentrations in serum. |
Jamal M |
2015 |
Effect of variation in BDNF Val66Met polymorphism, smoking, and nicotine dependence on symptom severity of depressive and anxiety disorders |
Jamal M |
2015 |
Longitudinal association between pain and depressive and anxiety disorders over four years. |
Gerrits MMJG |
2015 |
Depressive and anxiety disorders: Associated with losing or gaining weight over 2 years? |
de Wit LM |
2015 |
Chronic depression is associated with a decrease in serum Brain-Derived Neurotrophic Factor levels over time |
Bus BAA |
2015 |
Associations between life stress and subclinical cardiovascular disease are partly mediated by depressive and anxiety symptoms |
Bomhof-Roordink H |
2015 |
Differential associations of specific depressive and anxiety disorders with somatic symptoms |
Bekhuis E |
2015 |
Plasma cotinine levels in cigarette smokers: impact of mental health and other demographic and health correlates |
Bot M |
2014 |
Hemoglobin levels in persons with depressive and/or anxiety disorders |
Lever-van Milligen B |
2014 |
The association between low vitamin D and depressive disorders |
Milaneschi Y |
2014 |
Does tryptophan degradation along the kynurenine pathway mediate the association between pro-inflammatory immune activity and depressive symptoms? |
Quak J |
2014 |
Dysregulated physiological stress systems and accelerated cellular aging |
Révész D |
2014 |
Inflammatory and metabolic dysregulation and the 2-year course of depressive disorders |
Vogelzangs N |
2014 |
The association between inflammation and manic symptoms in patients with a depressive disorder |
Becking K |
2013 |
Differential association of somatic and cognitive symptoms of depression and anxiety with inflammation. Findings from the Netherlands Study of Depression and Anxiety (NESDA) |
Duivis H |
2013 |
Evidence for a differential role of HPA-axis function, inflammation and metabolic syndrome in melancholic versus atypical depression |
Lamers F |
2013 |
Dysregulation of the autonomic nervous system predicts the development of the metabolic syndrome |
Licht CMM |
2013 |
Sensitivity to depression or anxiety and subclinical cardiovascular disease |
Seldenrijk A |
2013 |
Longitudinal relationship of depressive and anxiety symptoms with dyslipidemia and abdominal obesity |
van Reedt-Dortland AKB |
2013 |
The impact of stress systems and lifestyle on dyslipidemia and obesity in anxiety and depression |
van Reedt-Dortland AKB |
2013 |
Evening sailvary alpha-amylase, major depressive disorder, and antidepressant use in the Netherlands Study of Depression and Anxiety. |
Veen G |
2013 |
Anxiety disorders and inflammation in a large adult cohort |
Vogelzangs N |
2013 |
Salivary cortisol levels and the 2-year course of depressive and anxiety disorders |
Vreeburg SA |
2013 |
Dysregulation of the autonomic nervous system and its association with the presence and intensity of chronic widespread pain |
Barakat A |
2012 |
Salivary testosterone, depressive and anxiety disorders, and antidepressant use: results from a large cohort study |
Giltay EJ |
2012 |
The relationships of working conditions, recent stressors and childhood trauma with salivary cortisol levels |
Holleman M |
2012 |
Effects of antidepressants, but not psychopathology, on cardiac sympathetic control: a longitudinal study |
Licht CMM |
2012 |
Serum BDNF concentrations show strong seasonal variation and correlations with the amount of ambient sunlight |
Molendijk ML |
2012 |
Gender specific associations of serum levels of brain-derived neurotrophic factor in anxiety |
Molendijk ML |
2012 |
Personality traits and childhood trauma as correlates of metabolic risk factors: The Netherlands Study of Depression and Anxiety (NESDA) |
van Reedt-Dortland A |
2012 |
Determinants of salivary evening alpha-amylase in a large sample free of psychopathology |
Veen G |
2012 |
Association of depressive disorders, depression characteristics and antidepressant medication with inflammation |
Vogelzangs N |
2012 |
Determinants of serum brain-derived neurotrophic factor in affective disorders (Determinanten van BDNF.) |
Bus BA |
2011 |
The impact of childhood abuse and recent stress on Brain-Derived Neurotrophic Factor and the moderating role of the BDNF gene. |
Elzinga BM |
2011 |
Co-occurring manic symptomatology influences HPA axis alterations in depression |
Jabben N |
2011 |
To include or not to include? A reply to Kemp et al. (Letter to the editor) |
Licht CM |
2011 |
Reply to: effects of serotonin reuptake inhibitors on heart rate variability: methodological issues, medical comorbidity, and clinical relevance |
Licht CM |
2011 |
Symptom dimensions of depression and anxiety and the metabolic syndrome |
Luppino F |
2011 |
Serum levels of Brain-Derived Neurotrophic Factor in Major Depressive Disorder: state-trait issues, clinical features and pharmacological treatment |
Molendijk ML |
2011 |
Psychological traits and the relationship with the Hypothalamus-Pituitary-Adrenal axis: Results from the Netherlands Study of Depression and Anxiety (NESDA) |
van Santen A |
2011 |
Depression, anxiety and arterial stiffness. |
Seldenrijk A |
2011 |
Carotid atherosclerosis in depression and anxiety: associations for age of depression onset. |
Seldenrijk A |
2011 |
Dimensions of depression and anxiety and the Hypothalamus-Pituitary-Adrenal axis: results from the Netherlands Study of Depression and Anxiety (NESDA). (Symptoomdimensies van depressie en angst en het stress systeem (Hypothalamus-Hypofyse-Bijnierschors-as).) |
Wardenaar K |
2011 |
Increased sympathetic and decreased parasympathetic activity rather than changes in hypothalamic-pituitary-adrenal axis activity is associated with metabolic abnormalities.(Het metabool syndroom hangt samen met een hoge hartslag en een lage hartslagvariabiliteit, maar niet met het stresshormoon cortisol) |
Licht CM |
2010 |
Longitudinal evidence for unfavorable effects of antidepressants on heart rate variability. (Ongewenste effecten van antidepressiva op de hartslagvariabliliteit) |
Licht CM |
2010 |
Long-term Benzodiazepine use and salivary cortisol |
Manthey L |
2010 |
Serum lipids and lipoproteins in subjects with current or remitted major depressive disorder and controls: the Netherlands Study of Depression and Anxiety. |
van Reedt-Dortland A |
2010 |
Metabolic syndrome abnormalities are associated with severity of anxiety and depression and with tricyclic antidepressant use. |
van Reedt-Dortland AKB |
2010 |
Molecular markers of Major Depressive Disorder based on stimulated gene expression in drug-naive blood samples |
Spijker S |
2010 |
Salivary cortisol levels in persons with and without different anxiety disorders. |
Vreeburg S |
2010 |
Parental history of depression or anxiety and the cortisol awakening response. |
Vreeburg S |
2010 |
Depression is associated with decreased blood pressure but antidepressant use increases the risk for hypertension. |
Licht MM |
2009 |
Association between anxiety disorders and heart rate variability in the Netherlands Study of Depression and Anxiety |
Licht CM |
2009 |
Major Depressive Disorder and HPA-axis activity: results from a large cohort study. |
Vreeburg SA |
2009 |
Associations between sociodemographic, sampling and health factors and various cortisol indicators in a large sample without psychopathology. |
Vreeburg SA |
2009 |
The association between major depressive disorder and heart rate variability in the Netherlands Study of Depression and Anxiety (NESDA). |
Licht CM |
2008 |